Table 8 PROGRESS DrotAA mortality and clinical outcomes
Variable | DrotAA n = 882 | Non-DrotAA n = 11,610 | Total n = 12,492 | P value |
|---|---|---|---|---|
Discharge location by DrotAA use, n (%): | (n = 807) | (n = 10,537) | (n = 11,344) | <0.001 |
   Died | 400 (49.6) | 5236 (49.7) | 5636 (49.7) |  |
   Community | 236 (29.2) | 3652 (34.7) | 3888 (34.3) |  |
   Other hospital | 73 (9.0) | 856 (8.1) | 929 (8.2) |  |
   Extended/Chronic care Institution | 83 (10.3) | 620 (5.9) | 703 (6.2) |  |
   Other/Unknown | 15 (1.9) | 173 (1.6) | 188 (1.7) |  |
Hospital mortality for DrotAA therapy, adjusted for Age, 7 OD*, Active Cancer, and Propensity Quartiles†| Adjusted Odds Ratio | 95% Confidence Interval | ---- | P value |
All patients** | 0.72 | 0.603 – 0.86 | ---- | 0.0003 |